Ortho Regenerative Enters Into MTA With Global Strategic Medical Company
07 Feb 2022 //
PRNEWSWIRE
ORTHO REGENERATIVE TECHNOLOGIES CLOSES NON-BROKERED $1.05 M
13 Dec 2021 //
YAHOO
Ortho Announces Successful Type A Meeting With FDA on CMC Elements
06 Oct 2021 //
BIOSPACE
FDA extends clinical hold on Ortho Regenerative`s IND Application for ORTHO-R
20 Aug 2021 //
PRNEWSWIRE
Ortho Regenerative Technologies Submits Formal Response to USFDA Clinical Hold
20 Jul 2021 //
PRNEWSWIRE